U.S. market Closed. Opens in 1 hour 18 minutes

NBY | NovaBay Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-31
Revenue14.73M14.40M8.42M9.93M6.60M12.51M18.23M11.90M4.38M1.05M3.48M6.95M11.02M9.75M15.68M6.72M5.91M1.53MN/AN/AN/A
Cost of Revenue6.83M6.62M2.78M3.97M1.74M1.50M2.78M2.46M1.26M486.00K162.00K8.00KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit7.89M7.78M5.64M5.96M4.86M11.01M15.45M9.43M3.12M568.00K3.31M6.94M11.02M9.75M15.68M6.72M5.91M1.53MN/AN/AN/A
Operating Expenses12.90M15.46M14.51M12.39M14.26M18.88M22.76M20.41M24.13M17.45M18.80M15.26M15.34M14.27M12.94M15.23M11.79M7.06M3.57M-2.80M953.00K
Selling, General & Admin12.83M15.29M14.46M12.11M14.08M18.62M22.35M19.04M18.09M7.93M6.34M5.98M5.43M5.65M5.61M5.64M4.37M2.97M1.62MN/AN/A
Research & Development68.00K174.00K44.00K285.00K184.00K259.00K410.00K1.37M6.04M9.51M12.46M9.28M9.91M8.62M7.34M9.60M7.42M4.09M1.95MN/A270.00K
Other Operating ExpensesN/A-276.00K-1.58M605.00K-1.43M19.00K12.00K-68.00K-96.00K22.00K1.00K-155.00KN/AN/AN/AN/AN/AN/AN/A-2.80MN/A
Operating Income-5.00M-7.68M-8.86M-6.43M-9.40M-7.87M-7.31M-10.98M-21.01M-16.88M-15.49M-8.31M-4.32M-4.52M2.74M-8.51M-5.88M-5.53M-3.57M-2.80M-953.00K
Other Expenses / Income-4.64M-2.78M3.04M-4.61M-252.00K1.33M-89.00K-2.17M2.04M1.71M-554.00K1.28M-762.00K258.00K-36.00K397.00K488.00K240.00K106.00KN/A-24.00K
Before Tax Income-9.64M-10.61M-5.82M-11.03M-9.65M-6.54M-7.40M-13.15M-18.97M-15.19M-16.04M-7.03M-5.08M-4.26M2.70M-8.11M-5.39M-5.29M-3.46MN/A-977.00K
Income Tax ExpensesN/A-3.81M-4.62M5.00K6.00K4.00K3.00K2.00K12.00K2.00K2.00K2.00K2.00K50.00K7.00K2.00K12.00K-240.00K-106.00K2.80MN/A
Net Income-9.64M-16.27M-6.56M-11.04M-10.49M-6.54M-7.40M-13.15M-18.97M-15.19M-16.04M-7.03M-5.08M-4.31M2.70M-8.11M-5.40M-5.29M-3.46M-2.80M-977.00K
Interest ExpensesN/AN/AN/AN/A1.05MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding120.43K30.00K31.64K28.63K16.27K11.60K12.51KN/AN/AN/AN/A33.46K29.45K26.66K25.60K24.36K10.26K6.53K5.54K5.00K4.62K
Diluted Shares Outstanding120.43K46.00K35.63K28.63K17.67K13.93K12.51KN/AN/AN/AN/A33.66K29.45K26.66K26.42K24.36K10.26K6.53K5.54K5.00K4.62K
EBITDA-4.80M-7.20M-8.74M-6.38M-9.34M-7.61M-7.22M-10.87M-20.97M-16.67M-15.17M-7.97M-3.90M-4.09M3.15M-7.81M-5.21M-5.45M-3.42M-2.80M-929.00K
EBITDA Margin-32.60%-49.97%-103.82%-64.17%-141.46%-60.80%-39.58%-91.35%-478.73%-1,581.78%-436.35%-114.70%-35.36%-41.92%20.08%-116.16%-88.03%-355.64%0.00%0.00%0.00%
EBIT-9.64M-20.07M-11.17M-11.03M-9.43M-6.54M-7.40M-13.15M-18.96M-15.19M-16.04M-7.03M-5.08M-4.26M2.70M-8.11M-5.39M-5.53M-3.57MN/A-977.00K
EBIT Margin-65.46%-139.36%-132.69%-111.07%-142.87%-52.29%-40.59%-110.52%-432.80%-1,441.37%-461.32%-101.12%-46.13%-43.65%17.24%-120.68%-91.12%-360.47%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙